Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Rankning i aktier #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Aktiekurs
$93.80
Senast synkroniserad: 2025-04-28
Marknadsvärde
$2.68B
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Aerovate Therapeutics, Inc. (AVTE)

Kategori

Historik för aktiesplit för Aerovate Therapeutics, Inc. (AVTE)
Aktien Aerovate Therapeutics, Inc. (symbol: AVTE) har genomgått totalt 1 aktiesplitar.
Den senaste spliten skedde den Apr 29, 2025.
En AVTE-aktie köpt före Apr 29, 2025 motsvarar nu 0.028571428571429 AVTE-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2025-04-29 1:35 x0.028571428571429 x0.028571428571429
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH